Drugs Made in America Acquisition Corp. (NASDAQ:DMAAU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DMAAU”, Tuesday, January 28, 2025.
The new SPAC intends to combined with a target company in the pharmaceutical industry that has products derived from plant-based raw materials.
Drugs Made in America’s sponsor team is led by Chief Executive Officer and Executive Chair Lynn Stockwell, and Chief Financial Officer Glenn Worman. Catherine Do, Sridhar Prasad and Myron W. Shulgan will serve on its Board of Directors.
Total SPAC deal count for 2025 year-to-date is now 6. This offering is expected to close on Wednesday, January 29, 2025.
Clear Street is acting as the sole book-running manager in the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Winston & Strawn LLP serving as Underwriter’s Counsel. MaloneBailey LLP serves as auditor. Wilmington Trust, National Association is acting as trustee.
Stellar V Capital Corp. (NASDAQ:SVCCU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SVCCU”, Thursday, January 30, 2025. The new SPAC intends to pursue a broad search process but with a focus on completing a combination with an established business of...
Cartesian Growth Corporation III has filed for a $200 million SPAC to give the Cartesian Growth team a fresher searching vehicle as it seeks to build on the success of its first business combination. The new SPAC has not overfunded its trust and will distribute 1/2 warrants inside of its units. This is something of...
Gesher Acquisition Corp. II (NASDAQ:GSHRU) has filed for a $125 million SPAC to bring an Israeli tech firm public with the help of underwriter BTIG. The Gesher team notched its first SPAC deal in 2023 after pricing its IPO in 2021, underwritten by EarlyBirdCapital with similar terms. This time it is shooting for a raise...
At the SPAC of Dawn The ripples cast by DeepSeek’s shockingly cheap AI model continue to be felt across the preferred target sectors of SPACs and many de-SPACs are attempting to show they can roll with these new punches. Indian car insurance technology de-SPAC Roadzen (NASDAQ:RDZN) just announced that it was integrating DeepSeek into its...
FG Merger II Corp. (NASDAQ:FGMCU) announced the pricing of its $80 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FGMCU”, Wednesday, January 29, 2025. The new SPAC intends to combine with a target company in the financial services industry in North America. FG Merger II’s sponsor team...